QCM
EW icon

Qsemble Capital Management’s Edwards Lifesciences EW Stock Holding History

Qsemble Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.04M Buy
46,825
+43,139
+1,170% +$3.83M 0.7% 35
2026
Q2 		$333K Buy
+3,686
New +$309K 0.04% 326
2024
Q4 		– Sell
-63,284
Closed -$4.18M – 435
2024
Q3 		$4.18M Buy
+63,284
New +$4.6M 0.77% 34
2023
Q4 		– Sell
-3,900
Closed -$270K – 392
2023
Q3 		$270K Buy
+3,900
New +$313K 0.05% 294

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Qsemble Capital Management's EW Position: Q3 2026 in Review

Qsemble Capital Management increased its Edwards Lifesciences (EW) stake by 1,170% in Q3 2026, buying an estimated $3.83M and bringing the position to 46,825 shares worth $4.04M. The position accounts for 0.7% of the portfolio, ranked #35.

Qsemble Capital Management first reported a position in EW in Q3 2023 and has held it in 4 quarters since. The position peaked at $4.18M in Q3 2024. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Qsemble Capital Management held 46,825 shares of Edwards Lifesciences worth $4.04M as of Q3 2026.
  • Qsemble Capital Management bought 43,139 Edwards Lifesciences shares in Q3 2026, an estimated $3.83M.
  • Edwards Lifesciences made up 0.7% of Qsemble Capital Management's portfolio in Q3 2026, its #35 holding.
  • Qsemble Capital Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 4 quarters since.
  • Qsemble Capital Management's Edwards Lifesciences position peaked at $4.18M in Q3 2024.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Qsemble Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.